» Articles » PMID: 17898281

Oxidative Stress is an Early Event in Hydrostatic Pressure Induced Retinal Ganglion Cell Damage

Overview
Specialty Ophthalmology
Date 2007 Sep 28
PMID 17898281
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine whether oxidative adduct formation or heme oxygenase-1 (HO-1) expression are altered in retinal ganglion cell (RGC) cultures exposed to elevated hydrostatic pressure and in a mouse model of glaucoma.

Methods: Cultured RGC-5 cells were subjected to 0, 30, 60, or 100 mm Hg hydrostatic pressure for 2 hours, and the cells were harvested. Parallel experiments examined the recovery from this stress, the effect of direct 4-hydroxy-2-nonenal (HNE) treatment, and the effect of pretreatment with resveratrol or quercetin. Mice were anesthetized and intraocular pressure was increased to 30, 60, or 100 mm Hg for 1 hour; then the retinas were harvested. HNE adduct formation and HO-1 expression were assessed by immunocytochemistry and immunoblotting.

Results: Increases of HNE-protein adducts (up to 5-fold) and HO-1 expression (up to 2.5 fold) in pressure-treated RGC-5 cells were dose dependent. During recovery experiments, HNE-protein adducts continued to increase for up to 10 hours; in contrast, HO-1 expression decreased immediately. HNE, at a concentration as low as 5 muM, led to neurotoxicity in RGC-5 cells. HNE adducts and HO-1 expression increased in the mouse retina and optic nerve after acute IOP elevation up to 5.5-fold and 2-fold, respectively. Antioxidant treatment reduced the oxidative stress level in pressure-treated RGC-5 cells.

Conclusions: This study demonstrates that oxidative stress is an early event in hydrostatic pressure/IOP-induced neuronal damage. These findings support the view that oxidative damage contributes early to glaucomatous optic neuropathy.

Citing Articles

Glaucoma: Current and New Therapeutic Approaches.

Lee H, Tsung T, Tsai Y, Chen Y, Lu D Biomedicines. 2024; 12(9).

PMID: 39335514 PMC: 11429057. DOI: 10.3390/biomedicines12092000.


Retinal Neurodegeneration in an Intraocular Pressure Fluctuation Rat Model.

Han J, Park C, Jung K Int J Mol Sci. 2024; 25(7).

PMID: 38612500 PMC: 11011540. DOI: 10.3390/ijms25073689.


Potential role of polysaccharides in glaucoma management: evidence from preclinical studies.

Lakshmanan Y, Wong F, So K, Chan H Neural Regen Res. 2023; 18(12):2623-2632.

PMID: 37449600 PMC: 10358649. DOI: 10.4103/1673-5374.355977.


m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases.

Ni Y, Zhang H, Chu L, Zhao Y Antioxidants (Basel). 2023; 12(2).

PMID: 36830067 PMC: 9952187. DOI: 10.3390/antiox12020510.


Erythropoietin in Glaucoma: From Mechanism to Therapy.

Lai Y, Lin T, Chen Y, Lu D Int J Mol Sci. 2023; 24(3).

PMID: 36769310 PMC: 9917746. DOI: 10.3390/ijms24032985.